COVID-19 and diabetes mellitus. Importance of glycemic control.
作者信息
Alonso Núria, Batule Sol
机构信息
Servicio Endocrinología y Nutrición. Hospital Universitari Germans Trias i Pujol, Badalona, España; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM).
Servicio Endocrinología y Nutrición. Hospital Universitari Germans Trias i Pujol, Badalona, España.
出版信息
Clin Investig Arterioscler. 2021 May-Jun;33(3):148-150. doi: 10.1016/j.arteri.2021.05.001.
Abstract
摘要
相似文献
1
COVID-19 and diabetes mellitus. Importance of glycemic control.2019冠状病毒病与糖尿病。血糖控制的重要性。
Clin Investig Arterioscler. 2021 May-Jun;33(3):148-150. doi: 10.1016/j.arteri.2021.05.001.
2
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.在 COVID-19 大流行期间，通过远程医疗对意大利的 1 型糖尿病儿童和青少年进行随访，改善血糖控制。
Front Endocrinol (Lausanne). 2020 Dec 7;11:595735. doi: 10.3389/fendo.2020.595735. eCollection 2020.
3
Glycemic control in type 1 diabetes mellitus and COVID-19 lockdown: What comes after a "quarantine"?1 型糖尿病患者的血糖控制与 COVID-19 封锁：“隔离”之后会发生什么？
J Diabetes. 2020 Dec;12(12):946-948. doi: 10.1111/1753-0407.13110. Epub 2020 Oct 2.
4
Glycemic Control of Patients with Type 1 Diabetes Using an Insulin Pump Before and During the COVID-19-Associated Quarantine.1型糖尿病患者在COVID-19相关隔离期间及之前使用胰岛素泵的血糖控制情况
Diabetes Technol Ther. 2021 Apr;23(4):320-321. doi: 10.1089/dia.2020.0423. Epub 2020 Nov 23.
5
Beyond Glycated Hemoglobin: Harnessing Data From Sensor-Based Technology to Improve Glucose Variability, Time in Range and Hypoglycemia in Adult Patients With Type 1 Diabetes.超越糖化血红蛋白：利用基于传感器技术的数据改善1型糖尿病成年患者的血糖变异性、血糖达标时间和低血糖情况
Can J Diabetes. 2021 Apr;45(3):269-272.e3. doi: 10.1016/j.jcjd.2020.08.103. Epub 2020 Sep 7.
6
Factors Related to Improvement of Glycemic Control Among Adults with Type 1 Diabetes During Lockdown Due to COVID-19.2019年冠状病毒病疫情封锁期间1型糖尿病成年患者血糖控制改善的相关因素
Diabetes Technol Ther. 2021 May;23(5):399-400. doi: 10.1089/dia.2020.0550. Epub 2020 Dec 8.
7
Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.在意大利 COVID-19 大流行期间，使用混合闭环系统控制血糖的 1 型糖尿病患者，并在之后接受远程医疗随访。
Diabetes Res Clin Pract. 2020 Nov;169:108440. doi: 10.1016/j.diabres.2020.108440. Epub 2020 Sep 12.
8
Does glycemic control affect outcome of COVID-19?血糖控制是否会影响新型冠状病毒肺炎的预后？
J Diabetes. 2020 Dec;12(12):868-869. doi: 10.1111/1753-0407.13116. Epub 2020 Oct 3.
9
Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic.在 2019 冠状病毒病（COVID-19）疫情期间，遵行居家检疫的糖尿病患者血糖控制的影响因素。
Diabetes Res Clin Pract. 2020 Dec;170:108514. doi: 10.1016/j.diabres.2020.108514. Epub 2020 Oct 15.
10
Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.COVID-19患者的地塞米松治疗：对糖尿病患者和非糖尿病患者血糖管理的影响及指导
Diabet Med. 2021 Jan;38(1):e14378. doi: 10.1111/dme.14378. Epub 2020 Sep 21.
引用本文的文献
1
Exome Sequence Data of Eight SLC Transporters Reveal That and Variants Alter Metformin Pharmacokinetics and Glycemic Control.八个溶质载体转运蛋白的外显子序列数据表明，[具体基因名称1]和[具体基因名称2]变体改变二甲双胍的药代动力学和血糖控制。
Pharmaceuticals (Basel). 2024 Oct 17;17(10):1385. doi: 10.3390/ph17101385.
2
Changes in glycemic control before and after COVID-19 quarantine.新冠疫情隔离前后血糖控制情况的变化。
Rev Peru Med Exp Salud Publica. 2023 Jul-Sep;40(3):372-373. doi: 10.17843/rpmesp.2023.403.12830. Epub 2023 Sep 25.
本文引用的文献
1
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown.新冠疫情封锁期间 1 型糖尿病患者远程医疗的疗效。
Nutr Diabetes. 2021 Jan 5;11(1):1. doi: 10.1038/s41387-020-00147-8.
2
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.患有糖尿病的人感染 COVID-19 疾病的风险和风险因素：苏格兰全人群的队列研究。
Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93. doi: 10.1016/S2213-8587(20)30405-8. Epub 2020 Dec 23.
3
Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis.COVID-19 住院患者达到住院血糖控制与临床结局的相关性：一项多中心、回顾性基于医院的分析。
Diabetes Care. 2021 Feb;44(2):578-585. doi: 10.2337/dc20-1857. Epub 2020 Dec 15.
4
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes.COVID-19 在糖尿病患者群体中的严重程度增加了两倍：对 1 型和 2 型糖尿病患者中疫情影响的前瞻性分析。
Diabetes Care. 2021 Feb;44(2):526-532. doi: 10.2337/dc20-2260. Epub 2020 Dec 2.
5
Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis.新冠病毒病患者中新诊断糖尿病的比例：一项系统评价与荟萃分析
Diabetes Obes Metab. 2021 Mar;23(3):870-874. doi: 10.1111/dom.14269. Epub 2020 Dec 29.
6
Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study.2019冠状病毒病封锁措施对血糖控制良好的2型糖尿病患者代谢控制的短期影响：一项单中心观察性研究
Acta Diabetol. 2021 Apr;58(4):431-436. doi: 10.1007/s00592-020-01637-y. Epub 2020 Nov 21.
7
Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study.2019冠状病毒病封锁期间长期糖尿病患者血糖控制的改善：一项前瞻性、观察性、巢式队列研究
Int J Diabetes Dev Ctries. 2020 Oct;40(4):476-481. doi: 10.1007/s13410-020-00880-x. Epub 2020 Oct 21.
8
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study.COVID-19 大流行对 1 型或 2 型糖尿病成人的早期影响：一项全国队列研究。
J Diabetes Complications. 2020 Dec;34(12):107748. doi: 10.1016/j.jdiacomp.2020.107748. Epub 2020 Oct 7.
9
Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study.肥胖与 2 型糖尿病患者 COVID-19 重症结局的关系：CORONADO 研究结果。
Diabetes Obes Metab. 2021 Feb;23(2):391-403. doi: 10.1111/dom.14228. Epub 2020 Nov 6.
10
The Impact of COVID-19 on CGM Use in the Hospital.2019冠状病毒病对医院持续葡萄糖监测使用的影响
Diabetes Care. 2020 Nov;43(11):2628-2630. doi: 10.2337/dci20-0046. Epub 2020 Sep 25.
Zotero 插件